News
Lilly's Once-Weekly Insulin Efsitora Meets Main Goals Across Three Phase 3 Trials In Type 2 Diabetes
Eli Lilly and Co. (LLY) announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials evaluating the safety and efficacy of investigational once-weekly insulin efsitora alfa ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
Discover the history, evolution, and importance of clinical trials, from James Lind's scurvy study to modern registry ...
The U.S. FDA ordered a pause on clinical trials of a combination therapy for HIV. This won't affect the company's other HIV ...
FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era ...
Risks of participating: There is a risk of side effects during Phase 1 clinical trials because researchers do not yet know which dose of treatment a person can tolerate without side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results